Pancreatic Cancer Research

ResearcherSouth Texas Veterans Health Care SystemActive in the last 2 years

Scott Kopetz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-9647-3416; OpenAlex author ID A5006348751, A5044880243; NIH RePORTER profile ID 8210070. Sources: ClinicalTrials.gov.

Their work

Papers
5
Trials
2 (principal investigator on 2)
Grants
3
Labs led
1
Collaborators
39
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 trials, 1 grant · 2023: 1 grant · 2024: 1 paper · 2025: none · 2026: 1 paper, 1 grant

Papers 5

  1. IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancer. Co-author DOI 10.1038/s41598-026-42259-8↗
  2. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarci… Co-author DOI 10.1136/jitc-2023-006822↗
  3. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-1664↗
  4. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0020636↗
  5. Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. Co-author PMID 21508395↗

Trials 2

  1. Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors Principal investigator NCT05194735↗
  2. Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs Principal investigator NCT05292859↗

Grants 3

  1. Stem Cell Biology & Cellular Therapy Program P30CA016672↗
  2. Administrative Core P50CA221707↗
  3. Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer U54CA224065↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elizabeth J. Shpall · 1 shared grant, 2026 · strength 0.71
  2. Albert C. Koong · 1 shared grant, 2026 · strength 0.71
  3. Kristy Brock · 1 shared grant, 2026 · strength 0.71
  4. Dihua Yu · 1 shared grant, 2026 · strength 0.71
  5. Mien‐Chie Hung · 1 shared grant, 2026 · strength 0.71
  6. Shubham Pant · 1 shared paper, 1 shared grant, 2023–2024 · strength 0.64
  7. Jason B. Fleming · 1 shared paper, 1 shared grant, 2011–2022 · strength 0.48
  8. Dipen M. Maru · 1 shared grant, 2023 · strength 0.48
  9. Anirban Maitra · 1 shared grant, 2023 · strength 0.48
  10. Gauri Rajani Varadhachary · 1 shared grant, 2023 · strength 0.48
  11. Funda Meric-Bernstam · 1 shared grant, 2022 · strength 0.45
  12. Jack Roth · 1 shared grant, 2022 · strength 0.45
  13. Akash R. Boda · 1 shared paper, 2026 · strength 0.27
  14. Manisha Singh · 1 shared paper, 2026 · strength 0.27
  15. Saikat Chowdhury · 1 shared paper, 2026 · strength 0.27
  16. Jason Roszik · 1 shared paper, 2026 · strength 0.27
  17. Michael A. Curran · 1 shared paper, 2026 · strength 0.27
  18. Milind M. Javle · 2 shared papers, 2011–2024 · strength 0.19
  19. Robert A. Wolff · 2 shared papers, 2011–2024 · strength 0.19
  20. Michael James Overman · 1 shared paper, 2024 · strength 0.16
  21. Chantale Bernatchez · 1 shared paper, 2024 · strength 0.16
  22. Donastas Sakellariou-Thompson · 1 shared paper, 2024 · strength 0.16
  23. Rodabe Navroze Amaria · 1 shared paper, 2024 · strength 0.16
  24. Patrick Hwu · 1 shared paper, 2024 · strength 0.16
  25. Amir Anthony Jazaeri · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.